Literature DB >> 6270663

A nucleotide change at a splice junction in the human beta-globin gene is associated with beta 0-thalassemia.

M Baird, C Driscoll, H Schreiner, G V Sciarratta, G Sansone, G Niazi, F Ramirez, A Bank.   

Abstract

beta 0-Thalassemia is a heterogeneous group of disorders associated with absence of beta-globin. In a survey of DNAs from patients with beta 0-thalassemia of diverse ethnic origins, a change at the splice junction at the 5' end of the large intervening sequence (IVS 2) of the human beta-globin gene has been found in one patient of Italian and another two of Iranian ethnic origins. The enzyme Hph I recognizes a change at this site and generates a large-than-normal fragment of DNA, which hybridizes specifically to a beta-globin IVS 2 probe. No other changes in beta-globin gene DNA structure or organization are detectable by extensive restriction endonuclease analysis. The enzyme HinfI which recognizes a sequence beginning three nucleotides from the 5' end of the IVS 2 splice junction, produces normal fragments and localizes the defect to a G-G-T sequence at the 5'-end IVS 2 splice junction. This sequence is known to be remarkably conserved in all globin genes from many species and in most other genes examined to date. Thus, in at least some beta 0-thalassemia patients, the beta 0-thalassemia defect is associated with a nucleotide change at a splice junction. These patients provide unique examples of naturally occurring defects in splice junctions of eukaryotic genes associated with absence of specific gene function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270663      PMCID: PMC319760          DOI: 10.1073/pnas.78.7.4218

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Haemoglobin Camperdown beta104(G6) arginine leads to serine.

Authors:  T Wilkinson; C G Chua; R W Carrell; H Robin; T Exner; K M Lee; H Kronenberg
Journal:  Biochim Biophys Acta       Date:  1975-05-30

2.  Abnormal or absent beta mRNA in betao Ferrara and gene deletion in delta beta thalassaemia.

Authors:  F Ramirez; J V O'Donnell; P A Marks; A Bank; S Musumeci; G Schilirò; G Pizzarelli; G Russo; B Luppis; R Gambino
Journal:  Nature       Date:  1976-10-07       Impact factor: 49.962

3.  Absence of messenger RNA for beta globin chain in beta(0) thalassaemia.

Authors:  B G Forget; E J Benz; A Skoultchi; C Baglioni; D Housman
Journal:  Nature       Date:  1974-02-08       Impact factor: 49.962

4.  Direct demonstration of beta-globin mRNA in homozygous Ferrara betaO-thalassaemia patients.

Authors:  S Ottolenghi; P Comi; B Giglioni; R Williamson; G Vullo; F Conconi
Journal:  Nature       Date:  1977-03-17       Impact factor: 49.962

5.  The thalassemia syndromes.

Authors:  A Bank
Journal:  Blood       Date:  1978-03       Impact factor: 22.113

6.  Decreased globin messenger RNA in thalassemia detected by molecular hybridization.

Authors:  D L Kacian; R Gambino; L W Dow; E Grossbard; C Natta; F Ramirez; S Spiegelman; P A Marks; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

7.  Characterization of beta-globin mRNA in the beta0 thalassemias.

Authors:  J M Old; N J Proudfoot; W G Wood; J I Longley; J B Clegg; D J Weatherall
Journal:  Cell       Date:  1978-06       Impact factor: 41.582

8.  Changes in restricted human cellular DNA fragments containing globin gene sequences in thalassemias and related disorders.

Authors:  J G Mears; F Ramirez; D Leibowitz; F Nakamura; A Bloom; F Konotey-Ahulu; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

9.  Demonstration of non-functional beta-globin mRNA in homozygous beta (0) thalassemia.

Authors:  Y W Kan; J P Holland; A M Dozy; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

10.  Relative stability of alpha- and beta-globin messenger RNAs in homozygous beta+ thalassemia.

Authors:  A W Nienhuis; P Turner; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

View more
  37 in total

1.  Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III.

Authors:  T Kamura; T Okamura; M Murakawa; H Tsuda; T Teshima; T Shibuya; M Harada; Y Niho
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  The molecular basis of beta thalassaemia in Bulgaria.

Authors:  L Kalaydjieva; A Eigel; J Horst
Journal:  J Med Genet       Date:  1989-10       Impact factor: 6.318

3.  Beta thalassaemia mutations in Sardinians: implications for prenatal diagnosis.

Authors:  C Rosatelli; G B Leoni; T Tuveri; M T Scalas; A Di Tucci; A Cao
Journal:  J Med Genet       Date:  1987-02       Impact factor: 6.318

4.  Nucleotide variations in the 3' A gamma enhancer region are linked to beta-gene cluster haplotypes and are unrelated to fetal hemoglobin expression.

Authors:  A Ragusa; M Lombardo; E Bouhassira; C Beldjord; T Lombardo; R L Nagel; D Labie; R Krishnamoorthy
Journal:  Am J Hum Genet       Date:  1989-07       Impact factor: 11.025

5.  Prenatal diagnosis of beta thalassaemia based on restriction endonuclease analysis of amplified fetal DNA.

Authors:  M Pirastu; M S Ristaldi; A Cao
Journal:  J Med Genet       Date:  1989-06       Impact factor: 6.318

6.  Stable transfer and expression of exogenous human globin genes in human erythroleukemia (K562) cells.

Authors:  K Young; M Donovan-Peluso; K Bloom; M Allan; J Paul; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

7.  DNA haplotype distribution in Algerian beta thalassaemia patients. An extended evaluation by family studies and representative molecular characterization.

Authors:  F Rouabhi; C Lapouméroulie; S Amselem; R Krishnamoorthy; L Adjrad; R Girot; P Chardin; M Benabdji; D Labie; C Beldjord
Journal:  Hum Genet       Date:  1988-08       Impact factor: 4.132

8.  Globin gene-associated restriction-fragment-length polymorphisms in southern African peoples.

Authors:  M Ramsay; T Jenkins
Journal:  Am J Hum Genet       Date:  1987-12       Impact factor: 11.025

9.  Carrier detection of Hemophilia B by using a restriction site polymorphism associated with the coagulation Factor IX gene.

Authors:  L Grunebaum; J P Cazenave; G Camerino; C Kloepfer; J L Mandel; P Tolstoshev; M Jaye; H De la Salle; J P Lecocq
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

10.  Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.

Authors:  P H Byers; J R Shapiro; D W Rowe; K E David; K A Holbrook
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.